Consequences of Temporomandibular Disorder on Balance Control

NCT ID: NCT03283839

Last Updated: 2018-01-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-06-19

Study Completion Date

2020-06-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the effects of the temporomandibular disorder (TMD) and its therapeutic care on postural control in somato-sensory and visual sensitization compared to control subjects matched on age, sex and lifestyle.

Parameters will be estimated by measures realized before the therapeutic care of the TMD (T0), then 2, 3 and 5 months after the starting care, both in TMD patients and control subjects. To evaluate also the effects of the TMD and its therapeutic care on balance control in various contexts of multi-sensory stimulation, orientation function, pain and tinnitus.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Primary objective: to evaluate the effects of the temporomandibular disorder (TMD) and its therapeutic care on postural control in somato-sensory and visual sensitization compared to control subjects matched on age, sex and lifestyle.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Temporomandibular Disorder Pathophysiology Therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Temporomandibular disorder

Group Type OTHER

Posturography

Intervention Type DIAGNOSTIC_TEST

Evaluation of postural control and of orientation function

Without temporomandibular disorder

Group Type OTHER

Posturography

Intervention Type DIAGNOSTIC_TEST

Evaluation of postural control and of orientation function

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Posturography

Evaluation of postural control and of orientation function

Intervention Type DIAGNOSTIC_TEST

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Orientation perception

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient group: TMD patients, care: occlusal splint therapy, behavioral advices
* Control group: matched with TMD patients (age, sex, lifestyle).

Exclusion Criteria

* Patient group: treatment generating secondary effects in postural control (psychotrop, antidepressor, antihypertensive drugs); osteoarticular pathologies and recent trauma (\< 4 months); vertigo and dysequilibrium (\< 6 months), whiplash
* Control group: id. and TMD.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Central Hospital, Nancy, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHRU de NANCY

Nancy, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Philippe PERRIN

Role: CONTACT

00 33 3 83 15 49 68

Nathalie PAOLI

Role: CONTACT

00 33 3 83 15 49 68

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Nathalie paoli

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2016-A01317-44

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.